Catalent Pharma ramps up specialty clinical packaging capabilities in Europe

26 February 2015 (Last Updated February 26th, 2015 18:30)

Catalent Pharma Solutions has expanded its speciality clinical packaging capabilities, a move that comes in response to increasing demand for handling highly potent or temperature-sensitive, investigational medical products.

Catalent Pharma Solutions has expanded its speciality clinical packaging capabilities, a move that comes in response to increasing demand for handling highly potent or temperature-sensitive, investigational medical products.

The company has equipped its facility in Schorndorf, Germany, with a second automated Inova packaging line from Optima Packaging for pre-filled syringes, with capabilities including plunger-rod insertion, application of single-panel labels, finger flanges, and safety device mounting.

The Schorndorf facility currently offers primary and secondary packaging for oral dose solids and pre-filled syringes; cold, frozen and controlled drug clinical storage; and EU-GMP audit, importation, release and consulting services.

"We are committed to offering comprehensive clinical supply solutions throughout our European network." 

Catalent Pharma has also installed two new energy-efficient chiller units at its primary packaging facility in Bolton, UK.

This will increase the Bolton plant's output capacity by more than 10%.

Catalent Pharma Solutions Clinical Supply Services vice-president and general manager Gerry Hepburn said: "As with our recent investments in our US capabilities, we are committed to offering comprehensive clinical supply solutions throughout our European network.

"A key part of that commitment is ensuring that our facilities are well aligned with the current, emerging and future needs of our customers, as evidenced by our recent investments in Europe and the harmonization of key systems across all Catalent sites."

Meanwhile, the company has also tripled its frozen storage at its Schorndorf facility, as well as expanded its clinical storage capacity at its controlled substances facility in Deeside, UK.

Catalent Pharma has also upgraded cold storage capabilities at its facility in Bathgate, UK, to include a cryogenic storage service, suitable for stem cells, regenerative therapies and other clinical materials.